Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q4 2025 value amounting to $252000.0.

  • Enanta Pharmaceuticals' Other Working Capital Changes rose 11602903.23% to $252000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $252000.0, marking a year-over-year increase of 11602903.23%. This contributed to the annual value of $379000.0 for FY2025, which is 9241.09% down from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Other Working Capital Changes of $252000.0 as of Q4 2025, which was up 11602903.23% from -$1.6 million recorded in Q3 2025.
  • Enanta Pharmaceuticals' Other Working Capital Changes' 5-year high stood at $4.5 million during Q4 2022, with a 5-year trough of -$9.8 million in Q2 2021.
  • In the last 5 years, Enanta Pharmaceuticals' Other Working Capital Changes had a median value of -$235391.5 in 2022 and averaged -$623639.2.
  • In the last 5 years, Enanta Pharmaceuticals' Other Working Capital Changes plummeted by 198152.17% in 2023 and then skyrocketed by 11602903.23% in 2025.
  • Enanta Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$2.7 million in 2021, then soared by 267.82% to $4.5 million in 2022, then tumbled by 122.73% to -$1.0 million in 2023, then soared by 100.02% to $217.0 in 2024, then soared by 116029.03% to $252000.0 in 2025.
  • Its Other Working Capital Changes was $252000.0 in Q4 2025, compared to -$1.6 million in Q3 2025 and $314000.0 in Q2 2025.